Application 076605
- Type
- ANDA
- Sponsor
- RANBAXY
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GABAPENTIN | GABAPENTIN | TABLET;ORAL | 600MG | No | No |
| 002 | GABAPENTIN | GABAPENTIN | TABLET;ORAL | 800MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A076605-001 | GABAPENTIN | GABAPENTIN | 600MG | TABLET / ORAL | 2005-09-14 | ||
| A076605-002 | GABAPENTIN | GABAPENTIN | 800MG | TABLET / ORAL | 2005-09-14 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-04-04 05:41 UTC | 2022-04 | A076605-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2005-09-14 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A076605-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2005-09-14 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A076605-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2005-09-14 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A076605-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2005-09-14 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A076605-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2005-09-14 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A076605-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2005-09-14 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A076605-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2005-09-14 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A076605-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2005-09-14 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A076605-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2005-09-14 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A076605-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2005-09-14 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A076605-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2005-09-14 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A076605-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2005-09-14 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A076605-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2005-09-14 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A076605-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2005-09-14 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A076605-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2005-09-14 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A076605-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2005-09-14 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A076605-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2005-09-14 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A076605-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2005-09-14 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A076605-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2005-09-14 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A076605-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2005-09-14 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A076605-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2005-09-14 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A076605-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2005-09-14 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A076605-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2005-09-14 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A076605-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2005-09-14 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A076605-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2005-09-14 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A076605-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2005-09-14 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A076605-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2005-09-14 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A076605-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2005-09-14 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A076605-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2005-09-14 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A076605-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2005-09-14 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A076605-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2005-09-14 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A076605-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2005-09-14 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A076605-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2005-09-14 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A076605-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2005-09-14 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A076605-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2005-09-14 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A076605-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2005-09-14 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A076605-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2005-09-14 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A076605-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2005-09-14 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A076605-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2005-09-14 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A076605-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2005-09-14 | 3bdfa0b2c4d7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | HAWAII REPACK, INC. | dd7adad2-e2f5-4b43-90a4-522bce0be5b3 | 2026-11-09 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Havix Group Inc d-b-a Aavis Pharmaceuticals | ad6c10e6-fc39-4ca2-942f-a56c4457e144 | 2026-11-06 | GABAPENTIN GABAPENTIN | |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 4615aaa7-73d4-4473-8f26-e7a982f8a166 | 2026-11-05 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 4c49d34d-bb47-406b-8f2d-b4834b2ee9d0 | 2026-11-04 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | c33c4d83-cc13-4104-9e24-d4cd40b17b70 | 2026-10-30 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | 5769d849-4f27-4701-97ec-7e3ca07339d7 | 2026-10-30 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | a1006139-7dfc-4d87-a5a9-aeb380c32d24 | 2026-10-30 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | e2d9bd8c-3bb9-4945-8e61-7d2703d9008c | 2026-10-30 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | fb726cb0-d422-48dd-a8ed-adbde812b005 | 2026-10-29 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | d8604417-9d43-4d27-a7ce-d4120ff201f4 | 2026-10-28 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 7f830664-2fa3-4d73-a154-775fbb8fd65d | 2026-10-28 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 6a0a75ac-e121-477b-a9d1-d11f588afc9d | 2026-10-28 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | 78088f6a-06a3-422f-b336-4a57a24adc16 | 2026-10-27 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| Gabapentin | GABAPENTIN | ScieGen Pharmaceuticals, Inc. | 5ab9c18b-9568-4dcb-90b0-252aef8f8dc2 | 2026-10-23 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Ascend Laboratories, LLC | 4d445d1d-02d1-4a59-b3b2-9ba5cd924c9a | 2026-10-23 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Northwind Health Company, LLC | 552912b2-be59-0333-e063-6394a90a85c0 | 2026-10-19 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | 5de61c1f-8e6f-b70a-e063-6294a90a1c21 | 2026-10-15 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | PD-Rx Pharmaceuticals, Inc. | b4c7388a-19d9-4e3a-83c9-4943fb855be4 | 2026-10-14 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | e877a425-2b7f-4e43-a1f9-24019cbf9685 | 2026-10-09 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Granules Pharmaceuticals Inc. | e847bcfa-f3de-404a-8a57-d8a414691e6a | 2026-10-08 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.